biotech Local Biotech Firm Develops Drug For Respiratory Distress In COVID-19 Patients By Maria Scapellato • Sep 8, 2020 CytoAgents Pittsburgh-based biotech company CytoAgents is launching into phase one of clinical trials this month on a drug designed to treat people with COVID-19 who develop serious respiratory distress when their immune system overreacts to the virus. Immunology Research Center Planned For Site Of Old Auto Plant On Baum Boulevard By Sarah Boden • Feb 14, 2018 University of Pittsburgh A new biotech incubator specializing in immunology will open in around two years at the site of a former Ford auto plant on Baum Boulevard.
